Affordable AI-guided all-in-one cervical cancer screening and treatment tool for low- and middle-income countries
A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICs
['FUNDING_R37'] · INTERNATIONAL AGENCY FOR RES ON CANCER · NIH-11403712
This project uses AI to screen women with a urine test and cervical photos to find high-risk HPV and guide same-visit triage and treatment decisions in low-resource settings.
Quick facts
| Phase | ['FUNDING_R37'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | INTERNATIONAL AGENCY FOR RES ON CANCER (nih funded) |
| Locations | 1 site (LYON, FRANCE) |
| Trial ID | NIH-11403712 on ClinicalTrials.gov |
What this research studies
If you take part, you would give a urine sample and have cervical images taken with a dedicated camera so an AI can look for high-risk HPV and signs of precancer. The team will use infrared spectroscopy on urine to flag HPV and an AI algorithm to read cervical photos to detect high-grade precancers and determine the transformation zone for treatment planning. The researchers already have a prototype camera and AI models and will improve them in the first two years and run larger validation work over the next three years. The work is focused on clinics in low- and middle-income countries where screening access is limited.
Who could benefit from this research
Good fit: Women of screening age in low- and middle-income countries who have not recently received cervical cancer screening are the ideal candidates.
Not a fit: People without a cervix, those already treated for cervical cancer, or individuals outside the study regions are unlikely to benefit from participation.
Why it matters
Potential benefit: If successful, this could provide fast, low-cost screening and help clinicians decide treatment at the point of care, potentially reducing cervical cancer in underserved areas.
How similar studies have performed: AI image-based cervical screening has shown promising results and preliminary urine spectroscopy work detected high-risk HPV, but combining both approaches for triage and treatment selection is relatively new.
Where this research is happening
LYON, FRANCE
- INTERNATIONAL AGENCY FOR RES ON CANCER — LYON, FRANCE (ACTIVE)
Researchers
- Principal investigator: BASU, PARTHA — INTERNATIONAL AGENCY FOR RES ON CANCER
- Study coordinator: BASU, PARTHA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus